These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14692944)

  • 1. The role of positron emission tomography in the management of colorectal cancer.
    Tutt AN; Plunkett TA; Barrington SF; Leslie MD
    Colorectal Dis; 2004 Jan; 6(1):2-9. PubMed ID: 14692944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new imaging technique for colorectal cancer: positron emission tomography.
    Flamen P; Van Cutsem E; Mortelmans L
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):22-9. PubMed ID: 11049029
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis of colorectal cancer with FDG-PET].
    Uno K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():168-72. PubMed ID: 14574875
    [No Abstract]   [Full Text] [Related]  

  • 4. Positron emission tomography in colorectal cancer.
    Flamen P
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):237-51. PubMed ID: 11969236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography and colorectal carcinoma: an update.
    Tzimas GN; Koumanis DJ; Meterissian S
    J Am Coll Surg; 2004 Apr; 198(4):645-52. PubMed ID: 15051018
    [No Abstract]   [Full Text] [Related]  

  • 6. Positron emission tomography and colorectal cancer.
    Arulampalam TH; Costa DC; Loizidou M; Visvikis D; Ell PJ; Taylor I
    Br J Surg; 2001 Feb; 88(2):176-89. PubMed ID: 11167864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma].
    Jörg L; Langsteger W
    Wien Med Wochenschr; 2002; 152(11-12):276-9. PubMed ID: 12138655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
    Laurens ST; Oyen WJ
    PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of recurrent colorectal cancer with positron emission tomography.
    Haji A
    Br J Hosp Med (Lond); 2007 Nov; 68(11):580-3. PubMed ID: 18087843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
    Watson AJ; Lolohea S; Robertson GM; Frizelle FA
    Dis Colon Rectum; 2007 Jan; 50(1):102-14. PubMed ID: 17115340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography (PET) in clinical oncology. Part II].
    Cabrera Villegas A; Gámez Cenzano C; Martín Urreta JC
    Rev Esp Med Nucl; 2002 Apr; 21(2):131-47; quiz 149-51. PubMed ID: 11879626
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
    Metser U; You J; McSweeney S; Freeman M; Hendler A
    AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.
    Ruhlmann J; Schomburg A; Bender H; Oehr P; Robertz-Vaupel GM; Vaupel H; Wolter H; Kozak B; Biersack HJ
    Dis Colon Rectum; 1997 Oct; 40(10):1195-204. PubMed ID: 9336115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Established, emerging and future roles of PET/CT in the management of colorectal cancer.
    Herbertson RA; Scarsbrook AF; Lee ST; Tebbutt N; Scott AM
    Clin Radiol; 2009 Mar; 64(3):225-37. PubMed ID: 19185652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Positron emission tomography/computed tomography in follow-up programmes for patients with colorectal cancer].
    Hansen AF; Jensen MR; Nordholm-Carstensen A
    Ugeskr Laeger; 2016 Sep; 178(37):. PubMed ID: 27649583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/CT in oncology: for which tumours is it the reference standard?
    Collins CD
    Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S77-87. PubMed ID: 17921085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography imaging of colorectal cancer.
    Akhurst T; Larson SM
    Semin Oncol; 1999 Oct; 26(5):577-83. PubMed ID: 10528907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F-fluorodeoxyglucose positron emission tomography in colorectal cancer: value in primary staging and follow-up].
    Jörg L; Heinisch M; Rechberger E; Kurz F; Klug R; Aufschnaiter M; Hammer J; Langsteger W
    Acta Med Austriaca; 2002; 29(5):176-9. PubMed ID: 12506769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical application of positron emission tomography to colorectal cancer management.
    Arulampalam TH; Costa DC; Bomanji JB; Ell PJ
    Q J Nucl Med; 2001 Sep; 45(3):215-30. PubMed ID: 11788814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.